These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1472149)

  • 21. Optimal timing of repeated rh-erythropoietin administration improves its effectiveness in stimulating erythropoiesis in healthy volunteers.
    Breymann C; Bauer C; Major A; Zimmermann R; Gautschi K; Huch A; Huch R
    Br J Haematol; 1996 Feb; 92(2):295-301. PubMed ID: 8602988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of erythropoietic activity on the basis of the red cell and reticulocyte distribution widths during epoetin beta therapy in patients undergoing cardiac surgery.
    Sowade O; Sowade B; Gross J; Brilla K; Ziemer S; Franke W; Stephan P; Scigalla P; Warnke H
    Acta Haematol; 1998; 99(1):1-7. PubMed ID: 9490558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human haemopoietic progenitor cells.
    Pierelli L; Menichella G; Scambia G; Teofili L; Iovino S; Serafini R; Benedetti Panici P; Salerno G; Rumi C; Zini G
    Bone Marrow Transplant; 1994 Jul; 14(1):23-30. PubMed ID: 7524905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
    Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
    Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental study of hemostimulating properties of the tablet form of recombinant human erythropoetin].
    Dygaĭ AM; Kolokol'tsova TD; Kostina NE; Minakova MIu; Nechaeva EA; Pozhen'ko NS; Sandakhchiev LS; Simanina EV; Khlusov IA
    Eksp Klin Farmakol; 2000; 63(5):37-40. PubMed ID: 11109524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An assessment of recombinant human erythropoietin effect on reticulocyte production rate and lifespan distribution in healthy subjects.
    Krzyzanski W; Perez-Ruixo JJ
    Pharm Res; 2007 Apr; 24(4):758-72. PubMed ID: 17318417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The erythropoietic effects of interleukin 6 and erythropoietin in vivo.
    Ulich TR; del Castillo J; Yin SM; Egrie JC
    Exp Hematol; 1991 Jan; 19(1):29-34. PubMed ID: 1989892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the efficacy of mast cell growth factor (c-kit ligand) in vitro as well as in vivo.
    Hintz-Obertreis P; Weinmann E; Seiler FR
    Behring Inst Mitt; 1991 Dec; (90):14-22. PubMed ID: 1724901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of recombinant human erythropoietin (rhEPO) on JAK2/STAT3 pathway and endothelial apoptosis in the rabbit basilar artery after subarachnoid hemorrhage.
    Chen G; Zhang S; Shi J; Ai J; Hang C
    Cytokine; 2009 Mar; 45(3):162-8. PubMed ID: 19144539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamics of recombinant human erythropoietin in murine bone marrow.
    Bugelski PJ; Nesspor T; Volk A; O'Brien J; Makropoulos D; Shamberger K; Fisher PW; James I; Graden D; Capocasale RJ
    Pharm Res; 2008 Feb; 25(2):369-78. PubMed ID: 17609863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Recombinant human erythropoietin: method of in vivo evaluation using normocythemic mice].
    Albertengo ME; Valcarce GA; Oliva LM; Baiges DL; Alonso BS; Chiale CA
    Sangre (Barc); 1999 Oct; 44(5):357-63. PubMed ID: 10618913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effect on cerebral inflammatory agents that accompany traumatic brain injury in a rat model: a potential neuroprotective mechanism of recombinant human erythropoietin (rhEPO).
    Chen G; Shi JX; Hang CH; Xie W; Liu J; Liu X
    Neurosci Lett; 2007 Oct; 425(3):177-82. PubMed ID: 17825990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of subcutaneous recombinant human erythropoietin in normal subjects: development of decreased reticulocyte hemoglobin content and iron-deficient erythropoiesis.
    Brugnara C; Colella GM; Cremins J; Langley RC; Schneider TJ; Rutherford CJ; Goldberg MA
    J Lab Clin Med; 1994 May; 123(5):660-7. PubMed ID: 8195672
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reticulocyte measurements as a bioassay for erythropoietin.
    Barbone AG; Aparicio B; Anderson DW; Natarajan J; Ritchie DM
    J Pharm Biomed Anal; 1994 Apr; 12(4):515-22. PubMed ID: 7918768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimal erythroid cell production during erythropoietin treatment of mice occurs by exploiting the splenic microenvironment.
    Nijhof W; Goris H; Dontje B; Dresz J; Loeffler M
    Exp Hematol; 1993 Apr; 21(4):496-501. PubMed ID: 8462658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men.
    Berglund B; Ekblom B
    J Intern Med; 1991 Feb; 229(2):125-30. PubMed ID: 1997637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.
    Meister B; Maurer H; Simma B; Kern H; Ulmer H; Hittmair A; Fink FM
    Stem Cells; 1997; 15(5):359-63. PubMed ID: 9323798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Erythropoietin, folic acid deficiency and hyperhomocysteinemia: is there a possible relationship in chronically hemodialyzed patients?
    Korzets A; Ori Y; Chagnac A; Weinstein T; Herman M; Zevin D; Malachi T; Gafter U
    Clin Nephrol; 2000 Jan; 53(1):48-54. PubMed ID: 10661482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A statistical pattern recognition approach for determining cellular viability and lineage phenotype in cultured cells and murine bone marrow.
    Quinn J; Fisher PW; Capocasale RJ; Achuthanandam R; Kam M; Bugelski PJ; Hrebien L
    Cytometry A; 2007 Aug; 71(8):612-24. PubMed ID: 17542025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.